To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST) alone and sulfasalazine (SSZ) in the treatment of psoriatic arthritis (PsA).
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis / Salvarani, Carlo; Macchioni, P; Olivieri, I; Marchesoni, A; Cutolo, M; Ferraccioli, G; Cantini, F; Salaffi, F; Padula, A; Lovino, C; Dovigo, L; Bordin, G; Davoli, C; Pasero, G; Alberighi, O. D.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 28:10(2001), pp. 2274-2282.
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis
SALVARANI, CARLO;
2001
Abstract
To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST) alone and sulfasalazine (SSZ) in the treatment of psoriatic arthritis (PsA).
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
